Elizabeth Yeu Lin - Jun 16, 2022 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Director
Signature
/s/ Samuel Gesten as attorney-in-fact for Dr. Elizabeth Yeu
Stock symbol
STAA
Transactions as of
Jun 16, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 06:41 PM
Previous filing
Jan 4, 2022
Next filing
Sep 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $0 +355 $0.00 355 Jun 16, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 +5.77K $0.00 5.77K Jun 16, 2022 Common Stock 5.77K $61.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock.
F2 The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to her continued service through the vesting date.

Remarks:

On June 16, 2022, STAAR Surgical Company granted Dr. Yeu, a non-employee director, 5765 options to purchase common stock of the Corporation on her re-election to the Board of Directors.